Supreme Court in India to Rule on Merck Fraud Regarding HPV Vaccine Deaths

Around the world legal problems regarding the HPV vaccine continue to multiply for Merck, yet this news is mostly censored out of the mainstream media. With multiple lawsuits pending in France over injuries due to the Gardasil HPV vaccine, one former Merck doctor in France even came out and stated that Gardasil will become "the greatest medical scandal of all time." In contrast, here in the U.S. any mainstream journalist that dares to suggest there are problems with the Gardasil vaccine puts their career on the line. Just ask Katie Couric, who dared to interview the mother of a young woman who died from the Gardasil vaccine. She was forced to issue an apology and have the assistant Surgeon General appear on her show to assure everyone the vaccine was safe. What is not revealed in the mainstream media, however, is that the U.S. government holds patents on Gardasil and also earns royalties from the sale of the vaccine. In the meantime, countries around the world are taking action to stop the carnage resulting from the HPV vaccine. Perhaps the most high-profile case you will never read about in the U.S. mainstream media is an upcoming Supreme Court hearing in India with a ruling due next month (August 2014). Merck has been charged with fraud and causing the death of young girls in India with vaccine trials due to the development of the HPV vaccine, sponsored by the U.S. organization PATH, with funding from the Bill and Melinda Gates Foundation. Last year (2013), we published a report from Christina England on a 43-page document produced by the Indian Parliament accusing the U.S. group, PATH, of committing illegal and improper activities in support of commercial interests in the development of the HPV vaccine in India, which led to the deaths of several young Indian girls. A few weeks later, Anita Jain, the India Editor of the British Medical Journal, published her own comments on the ethical violations conducted in India in the development of Gardasil, and questioned the wisdom of rolling out the Gardasil vaccine to the entire country, citing safety and efficacy concerns. Now, the India Supreme Court will decide on the case. But will the U.S. mainstream media even cover this story? So far, they have not.